FDA updates statistical approaches for assessing bioequivalence
Regulatory NewsJoanne S. Eglovitch
Chemistry, Manufacturing and Controls (CMC)Clinical TrialsComplianceNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy